Editas Medicine, Inc. Soared
Wed, Feb 19, 2025 at 07:27 PM

Editas Medicine, Inc. (EDIT:NASDAQ) shot up at $3.2, representing a gain of 83.9%. On Wed, Feb 19, 2025, EDIT:NASDAQ touched a New 2-Week High of $3.2. From Wed, Feb 05, 2025, the stock recorded 55.56% Up Days and 60.00% Green Days
About Editas Medicine, Inc. (EDIT:NASDAQ)
Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes.
Top 10 Gainers:
- JetAI Inc Com (JTAI:NASDAQ), 150%
- F45 Training Holdings Inc. (FXLV:NYSE), 92.08%
- Editas Medicine, Inc. (EDIT:NASDAQ), 83.91%
- OSR Holdings Inc. (OSRH:NASDAQ), 75.56%
- Sintx Technologies, Inc. (SINT:NASDAQ), 70.92%
- Lytus Technologies Holdings PTV. Ltd. (LYT:NASDAQ), 61.73%
- Aureus Greenway Holdings Inc. (AGH:NASDAQ), 42.44%
- HUHUTECH International Group Inc. (HUHU:NASDAQ), 32%
- MicroVision, Inc. (MVIS:NASDAQ), 31.58%
- ProPhase Labs, Inc. (PRPH:NASDAQ), 29.84%